HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Henricus F M van der Heijden Selected Research

Neoplasms (Cancer)

10/2010A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates.
6/2009The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer.
2/2009Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.
11/2007Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
10/2007Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.
10/2007Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Henricus F M van der Heijden Research Topics

Disease

6Neoplasms (Cancer)
10/2010 - 10/2007
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2012 - 10/2007
4Hypoxia (Hypoxemia)
06/2012 - 01/2005
3Lung Neoplasms (Lung Cancer)
12/2016 - 02/2009
1Type 2 Diabetes Mellitus (MODY)
12/2016
1Cardiovascular Diseases (Cardiovascular Disease)
12/2016
1Sarcoma (Soft Tissue Sarcoma)
08/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2012
1Adenocarcinoma
06/2012
1Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
09/2010
1Rupture
09/2010
1Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2009
1Carcinoma (Carcinomatosis)
02/2009
1Myocardial Infarction
08/2008
1Heart Failure
07/2007

Drug/Important Bio-Agent (IBA)

2ErbB Receptors (EGF Receptor)IBA
08/2012 - 06/2009
2DNA (Deoxyribonucleic Acid)IBA
10/2010 - 05/2010
2Proteins (Proteins, Gene)FDA Link
06/2009 - 01/2005
1P-2 (P 2)IBA
12/2016
1LipidsIBA
12/2016
1Triglycerides (Triacylglycerol)IBA
12/2016
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
08/2012
1Anaplastic Lymphoma KinaseIBA
08/2012
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
06/2012
1Adenosine Triphosphate (ATP)IBA
06/2012
1tenascin XIBA
09/2010
1Cell-Free Nucleic AcidsIBA
05/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2009
1Phosphotransferases (Kinase)IBA
06/2009
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2009
1tyrosine receptor (receptor, tyrosine)IBA
06/2009
1ORALIT (ORS)IBA
02/2009
1salicylhydroxamic acid (SHAM)IBA
08/2008
1Fluorine-18IBA
11/2007
1RadiopharmaceuticalsIBA
11/2007
1Glucose (Dextrose)FDA LinkGeneric
10/2007
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2007
1Myosins (Myosin)IBA
07/2007
1ebselenIBA
01/2005
1Peroxynitrous Acid (Peroxynitrite)IBA
01/2005
13-nitrotyrosineIBA
01/2005
1omega-N-Methylarginine (NG Monomethyl L Arginine)IBA
01/2005
1Oxidants (Oxidizing Agents)IBA
01/2005

Therapy/Procedure

3Therapeutics
02/2009 - 10/2007
2Drug Therapy (Chemotherapy)
06/2009 - 10/2007
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2010
1Radiotherapy
06/2009